Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Hvidovre

142 clinical trials in Hvidovre, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Hvidovre at a glance
142
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

142 trials in Hvidovre

Open in trial search
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bi 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab
  • Sponsor:AstraZeneca AB

Other cities in Denmark

The busiest research cities in the country

All 47 cities in Denmark

Clinical research in Hvidovre

What the registry says about research in the country

01 Infectious Disease Prevention

Research focusing on vaccine development and preventive measures against various infections, including studies on meningococcal vaccines for infants and Group B streptococcus prevention in pregnant women.

  • Meningococcal Infection Prevention
  • Streptococcal Disease Control
  • HIV Prevention Studies

Trials include evaluation of vaccine immunogenicity and safety profiles in different age groups.

02 Maternal and Women's Health

Innovative research addressing maternal mental health and pregnancy-related conditions, with studies focusing on postpartum depression prevention and maternal vaccination strategies.

  • Postpartum Depression Treatment
  • Pregnancy-Related Vaccinations
  • Caesarean Section Pain Management

Clinical investigations emphasize both maternal safety and infant outcomes.

03 Metabolic and Digestive Disorders

Comprehensive studies on inflammatory bowel diseases and metabolic conditions, including innovative treatments for obesity and diabetes management.

  • Crohn's Disease Therapies
  • Ulcerative Colitis Management
  • Weight Management Solutions

Trials evaluate both established and novel therapeutic approaches.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).